According to an agency press release issued Tuesday, the enforcement action centers on telehealth firms that marketed compounded versions of semaglutide, tirzepatide and liraglutide products, in ways that suggested equivalence with FDA-approved therapies such as Wegovy, Ozempic, Mounjaro and Zepbound
Wait a few minutes to determine if discomfort subsides
The role of an altered gut microbiome in Parkinson's disease: a narrative review
Paying attention to how you feel, not just what the scale shows, provides valuable information about whether treatment is proceeding normally or requires intervention
Theres no wellness coach texting reminders or nutritionists tweaking your meal plan
At the same time, communication remains an area for improvement